Figure 2.

28-Day mortality: heparin versus no heparin. Shown are 28-day all-cause mortality rates in patients with or without heparin prophylaxis during the 4-day study drug infusion according to prothrombin fragment (PF)1.2 plasma levels. TFPI, tissue factor pathway inhibitor.